5 Most Profitable Biotech Stocks Today

Page 5 of 5

1. Pfizer Inc. (NYSE:PFE)

Net Income TTM: $31.37 billion

Pfizer Inc. (NYSE:PFE) is a multinational pharmaceutical and biotech company based in the United States that operates a biopharma business which spans various therapeutic areas, such as vaccines, oncology, internal medicine, inflammation and immunology, and rare diseases. In partnership with BioNTech SE (NASDAQ:BNTX), this division worked to create the COVID-19 vaccine. As of December 11, 2022, over 4.3 billion doses of the Pfizer-BioNTech COVID-19 vaccine have been sent to 181 countries worldwide.

On January 31, 2023, Pfizer Inc. (NYSE:PFE) announced its Q4 2022 result, reporting revenue of $24.2 billion, beating market estimates by $98 million. The company’s Normalized EPS stood at $1.14, exceeding market expectations by $0.10.

As per Insider Monkey’s database, 75 hedge funds held stakes worth $2.5 billion in Pfizer Inc. (NYSE:PFE) in Q4 2022, compared to 77 funds in the prior quarter with stake worth $2.4 billion.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a look at Bill Gates’ Current Portfolio: 10 Dividend Stocks and 10 Best March Dividend Stocks to Buy.

Follow Insider Monkey on Twitter

Page 5 of 5